Professor Thomas Borody Interview – Part 2

In the second part of our interview with the esteemed Professor Thomas Borody from Australia, we discuss the question of ethical clinical trials, the progress in Australia with the Ivermectin-based tri-therapy he recommends for COVID-19, the role of State and federal authories. The interview also includes a message to Canada and other countries that deny early treatment to the population and the critical importance of the doctor patient relationship and the right for medical doctors to prescribe off-label. It’s important to realize that Professor Borody’s stance is contrary to the mainstream when it comes to therapeutics for COVID-19.